Reaction Details  Report a problem with these data
Target
D(3) dopamine receptor
Ligand
BDBM50081701
Substrate
n/a
Meas. Tech.
Radioligand Binding Assay
Ki
100.0±n/a nM
Citation
 Kristensen, JL; Jensen, AA; Märcher-Rørsted, E; Leth-Petersen, S 5-HT2A agonists for use in treatment of depression US Patent  US11642336 Publication Date 5/9/2023
Target
Name:
D(3) dopamine receptor
Synonyms:
DRD3 | DRD3_HUMAN | Dopamine D3 receptor
Type:
PROTEIN
Mol. Mass.:
44213.40
Organism:
Homo sapiens
Description:
ChEMBL_105671
Residue:
400
Sequence:
MASLSQLSGHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC
  
Inhibitor
Name:
BDBM50081701
Synonyms:
3-[2-(dimethylamino)ethyl]-1H-indol-4-ol | 4-hydroxy-N,N-dimethyltryptamine | CHEMBL65547 | N,N-dimethyl-4-hydroxytryptamine | Psilocin | US11427604, Compound (I-45) | US11453689, Compound Psilocin | US11591353, Compound I-45 | US11597738, Example 3 | US11642336, Compound Psilocin | US20240051978, Compound Psilocin
Type:
Small organic molecule
Emp. Form.:
C12H16N2O
Mol. Mass.:
204.2682
SMILES:
CN(C)CCc1c[nH]c2cccc(O)c12
Structure:
Search PDB for entries with ligand similarity: